help button home button Endocrine Society Molecular Endocrinology ENDO 08 Sessions Library
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Molecular Endocrinology Vol. 4, No. 5 758-765
doi:10.1210/mend-4-5-758
Copyright © 1990 by the Endocrine Society.
This Article
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pignataro, O. P.
Right arrow Articles by Ascoli, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pignataro, O. P.
Right arrow Articles by Ascoli, M.

Studies with Insulin and Insulin-Like Growth Factor-I Show that the Increased Labeling of Phosphatidylinositol-3,4-Bisphosphate Is not Sufficient to Elicit the Diverse Actions of Epidermal Growth Factor on MA-10 Leydig Tumor Cells

Omar P. Pignataro* and Mario Ascoli

The Population Council New York, New York 10021

Address requests for reprints to: Dr. Mario Ascoli, Department of Pharmacology, University of Iowa College of Medicine, Iowa City, Iowa 52242–1109.

Abstract

In a recent publication we showed that addition of mouse epidermal growth factor (mEGF) to MA-10 Leydig tumor cells rapidly leads to an increase in the incorporation of [3H]inositol-derived radioactivity into an unusual lipid that was identified as phosphatidylinositol-3,4-bisphosphate (PI-3,4-P2). Other ligands that are known to bind to MA-10 cells, such as hCG and arginine vasopressin, however, did not elicit this effect. Inasmuch as mEGF modulates the differentiated functions of MA-10 cells in a number of ways, our findings raised the possibility that PI-3,4-P2 may be an intracellular mediator of these actions of mEGF.

In an attempt to answer this question, we set out to determine if other ligands increase the labeling of PI-3,4-P2 in MA-10 cells prelabeled with [3H]inositol, and if such ligands mimic the diverse biological actions of mEGF on these cells. The experiments presented herein show that insulin, insulin-like growth factor-I, and transforming growth factor-{alpha} increase the labeling of PI-3,4-P2 in MA-10 cells, but only transforming growth factor-{alpha} mimics the actions of mEGF on the differentiated functions of MA-10 cells. We conclude that an increase in the labeling of PI-3,4-P2 is not sufficient to elicit these actions of mEGF.

FOOTNOTES

This work was supported by a grant from the NIH (CA-40629; to M.A.).

* Established Researcher from the National Research Council of Argentina (IBYME-CONICET), supported by a fellowship from the Andrew W. Mellon Foundation.

Received for publication January 15, 1990. Revision received February 21, 1990. Accepted for publication February 21, 1990.




This article has been cited by other articles:


Home page
J EndocrinolHome page
B. Piotrkowski, C. M Monzon, R. M Pagotto, C. G Reche, M. Besio, C. B Cymeryng, and O. P Pignataro
Effects of heme oxygenase isozymes on Leydig cells steroidogenesis
J. Endocrinol., October 1, 2009; 203(1): 155 - 165.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
C. Mondillo, R. M. Pagotto, B. Piotrkowski, C. G. Reche, Z. J. Patrignani, C. B. Cymeryng, and O. P. Pignataro
Involvement of Nitric Oxide Synthase in the Mechanism of Histamine-Induced Inhibition of Leydig Cell Steroidogenesis via Histamine Receptor Subtypes in Sprague-Dawley Rats
Biol Reprod, January 1, 2009; 80(1): 144 - 152.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
P. R. Manna, S. P. Chandrala, S. R. King, Y. Jo, R. Counis, I. T. Huhtaniemi, and D. M. Stocco
Molecular Mechanisms of Insulin-like Growth Factor-I Mediated Regulation of the Steroidogenic Acute Regulatory Protein in Mouse Leydig Cells
Mol. Endocrinol., February 1, 2006; 20(2): 362 - 378.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Balbis, G. Baquiran, C. Mounier, and B. I. Posner
Effect of Insulin on Caveolin-enriched Membrane Domains in Rat Liver
J. Biol. Chem., September 17, 2004; 279(38): 39348 - 39357.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
A. Chamson-Reig, O. P. Pignataro, C. Libertun, and V. A. R. Lux-Lantos
Alterations in Intracellular Messengers Mobilized by Gonadotropin-Releasing Hormone in an Experimental Ovarian Tumor
Endocrinology, August 1, 1999; 140(8): 3573 - 3580.
[Abstract] [Full Text]


Home page
J. Cell Sci.Home page
M Brignoni, O. Pignataro, M. Rodriguez, A Alvarez, D. Vega-Salas, E Rodriguez-Boulan, and P. Salas
Cyclic AMP modulates the rate of 'constitutive' exocytosis of apical membrane proteins in Madin-Darby canine kidney cells
J. Cell Sci., January 5, 1995; 108(5): 1931 - 1943.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1990 by The Endocrine Society